Summary of HR 1947 - TREAT PTSD Act

Overview

The TREAT PTSD Act (H.R. 1947) is a legislative proposal aimed at addressing the mental health needs of individuals suffering from Post-Traumatic Stress Disorder (PTSD). The bill seeks to enhance access to innovative therapies and treatments for PTSD, particularly for veterans and active-duty military personnel.

Purpose and Intent

The primary purpose of the TREAT PTSD Act is to improve the quality of life for those affected by PTSD by facilitating the development and accessibility of emerging therapies. The bill recognizes the urgent need for effective treatment options, given the increasing prevalence of PTSD among veterans and other populations exposed to traumatic events.

Key Provisions

While the full text of the bill is not provided, the following key provisions can be anticipated based on the bill's title and intent:

• Emerging Therapies: The bill may include provisions to promote research and development of new therapeutic approaches for PTSD, including but not limited to pharmacological treatments, psychotherapy, and alternative therapies.

• Accessibility: The legislation is likely to focus on improving access to these therapies for veterans and active-duty military personnel, potentially through funding initiatives or partnerships with healthcare providers.

• Collaboration: The bill may encourage collaboration between the Department of Defense, the Department of Veterans Affairs, and private sector entities to expedite the availability of effective PTSD treatments.

Affected Parties

The TREAT PTSD Act primarily targets:

• Veterans: Individuals who have served in the military and are experiencing PTSD as a result of their service.

• Active-Duty Military Personnel: Service members currently in the military who may be at risk for developing PTSD due to combat or other traumatic experiences.

• Healthcare Providers: Organizations and professionals involved in the treatment of PTSD, including hospitals, clinics, and mental health specialists.

Legislative Process and Timeline

• Introduced: March 6, 2025
• Referred to Committees: The bill was referred to the Committee on Armed Services and the Committee on Veterans' Affairs for consideration.
• Subcommittee Referral: On March 27, 2025, the bill was referred to the Subcommittee on Health for further examination.

Sponsors

The TREAT PTSD Act is sponsored by a bipartisan group of legislators, including:

• Scott Perry (Primary Sponsor)
• Chrissy Houlahan (Cosponsor)
• Madeleine Dean (Cosponsor)
• Richard McCormick (Cosponsor)
• Andrew Ogles (Cosponsor)
• Paul A. Gosar (Cosponsor)
• Dan Crenshaw (Cosponsor)
• Brian K. Fitzpatrick (Cosponsor)
• Jefferson Van Drew (Cosponsor)
• Gregory F. Murphy (Cosponsor)
• Gus M. Bilirakis (Cosponsor)
• David G. Valadao (Cosponsor)
• Troy E. Nehls (Cosponsor)

Conclusion

The TREAT PTSD Act represents a significant step towards addressing the mental health crisis associated with PTSD, particularly among veterans and active-duty military personnel. By focusing on emerging therapies and improving access, the bill aims to provide much-needed relief to those affected by this debilitating condition. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and funding mechanisms.